Literature DB >> 31529157

Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers.

Zehra Yavas Abali1, Gozde Yesil2, Tarık Kirkgoz1, Neslihan Cicek3, Harika Alpay3, Serap Turan1, Abdullah Bereket1, Tulay Guran4.   

Abstract

Entities:  

Keywords:  Familial hyperkalemic hypertension; Gordon syndrome; Low renin hypertension; Pseudohypoaldosteronism type 2

Year:  2019        PMID: 31529157     DOI: 10.1007/s00467-019-04352-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  13 in total

1.  Familial hyperkalemic hypertension (Gordon syndrome): evidence for phenotypic variability in a study of 7 families.

Authors:  S Disse-Nicodème; J M Achard; J Potier; M Delahousse; B Fiquet-Kempf; N Stern; A Blanchard; J C Guilbaud; P Niaudet; D Chauveau; B Dussol; Y Berland; P Dequiedt; J L Ader; M Paillard; J P Grünfeld; A Fournier; P Corvol; X Jeunemaitre
Journal:  Adv Nephrol Necker Hosp       Date:  2001

2.  WNK kinases regulate thiazide-sensitive Na-Cl cotransport.

Authors:  Chao-Ling Yang; Jordan Angell; Rose Mitchell; David H Ellison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Chronic acidosis-induced growth retardation is mediated by proton-induced expression of Gs protein.

Authors:  Ruth Goldberg; Ella Reshef-Bankai; Raymond Coleman; Jacob Green; Gila Maor
Journal:  J Bone Miner Res       Date:  2006-05       Impact factor: 6.741

4.  Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans.

Authors:  M Brüngger; H N Hulter; R Krapf
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

Review 5.  Monogenic forms of hypertension.

Authors:  Giacomo Domenico Simonetti; Markus G Mohaupt; Mario G Bianchetti
Journal:  Eur J Pediatr       Date:  2011-03-15       Impact factor: 3.183

Review 6.  Diagnosis and treatment of low-renin hypertension.

Authors:  Paolo Mulatero; Andrea Verhovez; Fulvio Morello; Franco Veglio
Journal:  Clin Endocrinol (Oxf)       Date:  2007-06-15       Impact factor: 3.478

7.  Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.

Authors:  Haim Mayan; Gabriel Munter; Miriam Shaharabany; Meir Mouallem; Rachel Pauzner; Eliezer J Holtzman; Zvi Farfel
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

8.  Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.

Authors:  Lynn M Boyden; Murim Choi; Keith A Choate; Carol J Nelson-Williams; Anita Farhi; Hakan R Toka; Irina R Tikhonova; Robert Bjornson; Shrikant M Mane; Giacomo Colussi; Marcel Lebel; Richard D Gordon; Ben A Semmekrot; Alain Poujol; Matti J Välimäki; Maria E De Ferrari; Sami A Sanjad; Michael Gutkin; Fiona E Karet; Joseph R Tucci; Jim R Stockigt; Kim M Keppler-Noreuil; Craig C Porter; Sudhir K Anand; Margo L Whiteford; Ira D Davis; Stephanie B Dewar; Alberto Bettinelli; Jeffrey J Fadrowski; Craig W Belsha; Tracy E Hunley; Raoul D Nelson; Howard Trachtman; Trevor R P Cole; Maury Pinsk; Detlef Bockenhauer; Mohan Shenoy; Priya Vaidyanathan; John W Foreman; Majid Rasoulpour; Farook Thameem; Hania Z Al-Shahrouri; Jai Radhakrishnan; Ali G Gharavi; Beatrice Goilav; Richard P Lifton
Journal:  Nature       Date:  2012-01-22       Impact factor: 49.962

9.  A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3.

Authors:  Shoji Tsuji; Miyoko Yamashita; Gen Unishi; Reiko Takewa; Takahisa Kimata; Kiyoshi Isobe; Motoko Chiga; Shinichi Uchida; Kazunari Kaneko
Journal:  BMC Nephrol       Date:  2013-07-31       Impact factor: 2.388

Review 10.  Gordon Syndrome: a continuing story.

Authors:  Kevin M O'Shaughnessy
Journal:  Pediatr Nephrol       Date:  2014-12-11       Impact factor: 3.714

View more
  1 in total

Review 1.  Kelch-like protein 3 in human disease and therapy.

Authors:  Yan Lin; Qian Li; Xiaofeng Jin
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.